- Q1 2024 Viking Therapeutics Inc Earnings Call TranscriptApr 24, 2024$65.07 (+0.22%)Earnings
- Viking Therapeutics Inc Phase 2 VENTURE Trial of VK2735 Results Call TranscriptFeb 27, 2024
- Q4 2023 Viking Therapeutics Inc Earnings Call TranscriptFeb 07, 2024$24.48 (-0.53%)Earnings
- Q3 2023 Viking Therapeutics Inc Earnings Call TranscriptOct 25, 2023$10.67 (+0.19%)Earnings
- Q2 2023 Viking Therapeutics Inc Earnings Call TranscriptJul 26, 2023$14.28 (-1.45%)Earnings
- Viking Therapeutics Inc Top-Line Results from Phase 2b VOYAGE Study of VK2809 Call TranscriptMay 16, 2023
- Q1 2023 Viking Therapeutics Inc Earnings Call TranscriptApr 26, 2023$19.55 (-1.66%)Earnings
- Q4 2022 Viking Therapeutics Inc Earnings Call TranscriptFeb 08, 2023$9.56 (-4.02%)Earnings
- Q3 2022 Viking Therapeutics Inc Earnings Call TranscriptOct 26, 2022$4.15 (+1.47%)Earnings
- Q2 2022 Viking Therapeutics Inc Earnings Call TranscriptJul 27, 2022$3.18 (-2.45%)Earnings
- Q1 2022 Viking Therapeutics Inc Earnings Call TranscriptApr 27, 2022$2.2 (-3.93%)Earnings
- Q4 2021 Viking Therapeutics Inc Earnings Call TranscriptFeb 09, 2022$3.73 (+3.90%)Earnings
- Q3 2021 Viking Therapeutics Inc Earnings Call TranscriptNov 03, 2021$6.58 (+3.30%)Earnings
- Q2 2021 Viking Therapeutics Inc Earnings Call TranscriptJul 28, 2021$5.86 (+2.99%)Earnings
- Q1 2021 Viking Therapeutics Inc Earnings Call TranscriptApr 28, 2021$6.36 (+2.09%)Earnings
- Q4 2020 Viking Therapeutics Inc Earnings Call TranscriptFeb 17, 2021$8.27 (-2.36%)Earnings
- Q3 2020 Viking Therapeutics Inc Earnings Call TranscriptOct 28, 2020$5.3 (-4.85%)Earnings
- Q2 2020 Viking Therapeutics Inc Earnings Call TranscriptJul 29, 2020$6.61 (+0.30%)Earnings
- Viking Therapeutics Inc at UBS Global Healthcare Conference (Virtual) TranscriptMay 18, 2020
- Q1 2020 Viking Therapeutics Inc Earnings Call TranscriptApr 30, 2020$5.76 (-7.10%)Earnings
- Q4 2019 Viking Therapeutics Inc Earnings Call TranscriptFeb 26, 2020$6.23 (-2.20%)Earnings
- Q3 2019 Viking Therapeutics Inc Earnings Call TranscriptNov 05, 2019$7.82 (+19.21%)Earnings
- Viking Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptOct 02, 2019
- Q2 2019 Viking Therapeutics Inc Earnings Call TranscriptAug 01, 2019$7.57 (-1.56%)Earnings
- Q1 2019 Viking Therapeutics Inc Earnings Call TranscriptMay 02, 2019$8.15 (+3.95%)Earnings
- Q4 2018 Viking Therapeutics Inc Earnings Call TranscriptMar 13, 2019$8.25 (+3.38%)Earnings
Viking Therapeutics Inc Top-Line Results from Phase 2b VOYAGE Study of VK2809 Call Transcript
Good morning, everyone, and welcome to the Viking Therapeutics Phase IIb VOYAGE study top-line data conference call. (Operator Instructions).
As a reminder, this conference call is being recorded today, May 16, 2023. I would now like to turn the floor over to Viking's Manager of Investor Relations, Stephanie Diaz. Please go ahead, Stephanie.
Hello, and thank you all for participating in today's call. Joining me today is Brian Lian, Viking's President and CEO; Marianne Mancini, the company's Chief Operating Officer; and Greg Zante, Viking's Chief Financial Officer.
Before we begin, I'd like to caution that comments made during this conference call today, May 16, 2023, will contain forward-looking statements under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including statements about Viking's expectations regarding its development activities, timelines and milestones.
Forward-looking statements are subject to risks and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)